Detalles de la búsqueda
1.
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.
EClinicalMedicine
; 72: 102622, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38745965
2.
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).
Signal Transduct Target Ther
; 8(1): 58, 2023 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36750721
3.
[Combined three-dimensional conformal radiotherapy plus transcatheter arterial chemoembolization and surgical intervention for portal vein tumor thrombus in patients with hepatocellular carcinoma].
Zhonghua Yi Xue Za Zhi
; 91(40): 2841-4, 2011 Nov 01.
Artículo
en Zh
| MEDLINE | ID: mdl-22333546
4.
Expression of leucine aminopeptidase 3 (LAP3) correlates with prognosis and malignant development of human hepatocellular carcinoma (HCC).
Int J Clin Exp Pathol
; 7(7): 3752-62, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25120751
Resultados
1 -
4
de 4
1
Próxima >
>>